|
1
|
Jaffe ES: The 2008 WHO classification of
lymphomas: Implications for clinical practice and translational
research. Hematology Am Soc Hematol Educ Program. 523–531. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Molyneux EM, Rochford R, Griffin B, Newton
R, Jackson G, Menon G, Harrison CJ, Israels T and Bailey S:
Burkitt's lymphoma. Lancet. 379:1234–1244. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferry JA: Burkitt's lymphoma:
Clinicopathologic features and differential diagnosis. Oncologist.
11:375–383. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Neilson LI, Schneider PA, Van Deerlin PG,
Kiriakidou M, Driscoll DA, Pellegrini MC, Millinder S, Yamamoto KK,
French CK and Strauss JF III: cDNA cloning and characterization of
a human sperm antigen (SPAG6) with homology to the product of the
Chlamydomonas PF16 locus. Genomics. 60:272–280. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sapiro R, Kostetskii I, Olds-Clarke P,
Gerton GL, Radice GL and Strauss IJ: Male infertility, impaired
sperm motility, and hydrocephalus in mice deficient in
sperm-associated antigen 6. Mol Cell Biol. 22:6298–6305. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Z, Jones BH, Tang W, Moss SB, Wei Z,
Ho C, Pollack M, Horowitz E, Bennett J, Baker ME and Strauss JF
III: Dissecting the axoneme interactome: The mammalian orthologue
of Chlamydomonas PF6 interacts with sperm-associated antigen 6, the
mammalian orthologue of Chlamydomonas PF16. Mol Cell Proteomics.
4:914–923. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lonergan KM, Chari R, Deleeuw RJ, Shadeo
A, Chi B, Tsao MS, Jones S, Marra M, Ling V, Ng R, et al:
Identification of novel lung genes in bronchial epithelium by
serial analysis of gene expression. Am J Respir Cell Mol Biol.
35:651–661. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Altenberger C, Heller G, Ziegler B,
Tomasich E, Marhold M, Topakian T, Müllauer L, Heffeter P, Lang G,
End-Pfützenreuter A, et al: SPAG6 and L1TD1 are transcriptionally
regulated by DNA methylation in non-small cell lung cancers. Mol
Cancer. 16:12017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Steinbach D, Schramm A, Eggert A, Onda M,
Dawczynski K, Rump A, Pastan I, Wittig S, Pfaffendorf N, Voigt A,
et al: Identification of a set of seven genes for the monitoring of
minimal residual disease in pediatric acute myeloid leukemia. Clin
Cancer Res. 12:2434–2441. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang L, Fidler C, Nadig N, Giagounidis A,
Della Porta MG, Malcovati L, Killick S, Gattermann N, Aul C,
Boultwood J and Wainscoat JS: Genome-wide analysis of copy number
changes and loss of heterozygosity in myelodysplastic syndrome with
del(5q) using high-density single nucleotide polymorphism arrays.
Haematologica. 93:994–1000. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang B, Wang L, Luo X, Chen L, Yang Z and
Liu L: SPAG6 silencing inhibits the growth of the malignant myeloid
cell lines SKM-1 and K562 via activating p53 and caspase
activation-dependent apoptosis. Int J Oncol. 46:649–656. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Z, Jensen MA and Zenklusen JC: A
practical guide to the cancer genome atlas (TCGA). Methods Mol
Biol. 1418:111–141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Prasad A, Jia Y, Roy SG, Loison F,
Mondal S, Kocjan P, Silberstein LE, Ding S and Luo HR: Pretreatment
with phosphatase and tensin homolog deleted on chromosome 10 (PTEN)
inhibitor SF1670 augments the efficacy of granulocyte transfusion
in a clinically relevant mouse model. Blood. 117:6702–6713. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li L, Li Y, Que X, Gao X, Gao Q, Yu M, Ma
K, Xi Y and Wang T: Prognostic significances of overexpression MYC
and/or BCL2 in R-CHOP-treated diffuse large B-cell lymphoma: A
systematic review and meta-analysis. Sci Rep. 8:62672018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rochford R and Moormann AM: Burkitt's
lymphoma. Curr Top Microbiol Immunol. 390:267–285. 2015.PubMed/NCBI
|
|
16
|
Martin GS: Cell signaling and cancer.
Cancer Cell. 4:167–174. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Adem J, Eray M, Eeva J, Nuutinen U and
Pelkonen J: The combination of TRAIL and MG-132 induces apoptosis
in both TRAIL-sensitive and TRAIL-resistant human follicular
lymphoma cells. Leuk Res. 66:57–65. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jaffe ES and Pittaluga S: Aggressive
B-cell lymphomas: A review of new and old entities in the WHO
classification. Hematology Am Soc Hematol Educ Program.
2011:506–514. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vervoorts J, Luscher-Firzlaff J and
Luscher B: The ins and outs of MYC regulation by posttranslational
mechanisms. J Biol Chem. 281:34725–34729. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Waniczek D, Snietura M, Lorenc Z,
Nowakowska-Zajdel E and Muc-Wierzgon M: Assessment of PI3K/AKT/PTEN
signaling pathway activity in colorectal cancer using quantum dot-
conjugated antibodies. Oncol Lett. 15:1236–1240. 2018.PubMed/NCBI
|
|
21
|
Capodanno A, Camerini A, Orlandini C,
Baldini E, Resta ML, Bevilacqua G and Collecchi P: Dysregulated
PI3K/Akt/PTEN pathway is a marker of a short disease-free survival
in node- negative breast carcinoma. Hum Pathol. 40:1408–1417. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hamada T, Teraoka M, Imaki J, Ui-Tei K,
Ladher RK and Asahara T: Gene expression of Spag6 in chick central
nervous system. Anat Histol Embryol. 39:227–232. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yan R, Hu X, Zhang Q, Song L, Zhang M,
Zhang Y and Zhao S: Spag6 negatively regulates neuronal migration
during mouse brain development. J Mol Neurosci. 57:463–469. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu X, Yan R, Cheng X, Song L, Zhang W, Li
K and Zhao S: The function of sperm-associated antigen 6 in
neuronal proliferation and differentiation. J Mol Histol.
47:531–540. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mulaw MA, Krause A, Deshpande AJ, Krause
LF, Rouhi A, La Starza R, Borkhardt A, Buske C, Mecucci C, Ludwig
WD, et al: CALM/AF10-positive leukemias show upregulation of genes
involved in chromatin assembly and DNA repair processes and of
genes adjacent to the breakpoint at 10p12. Leukemia. 26:1012–1019.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Steinbach D, Bader P, Willasch A,
Bartholomae S, Debatin KM, Zimmermann M, Creutzig U, Reinhardt D
and Gruhn B: Prospective validation of a new method of monitoring
minimal residual disease in childhood acute myelogenous leukemia.
Clin Cancer Res. 21:1353–1359. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gonzalvez F and Ashkenazi A: New insights
into apoptosis signaling by Apo2L/TRAIL. Oncogene. 29:4752–4765.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li X, Yang B, Wang L, Chen L, Luo X and
Liu L: SPAG6 regulates cell apoptosis through the TRAIL signal
pathway in myelodysplastic syndromes. Oncol Rep. 37:2839–2846.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kuo YC, Huang KY, Yang CH, Yang YS, Lee WY
and Chiang CW: Regulation of phosphorylation of Thr-308 of Akt,
cell proliferation, and survival by the B55alpha regulatory subunit
targeting of the protein phosphatase 2A holoenzyme to Akt. J Biol
Chem. 283:1882–1892. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ramezani A, Nikravesh H and Faghihloo E:
The roles of FOX proteins in virus-associated cancers. J Cell
Physiol. 234:3347–3361. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jiang M, Chen Y, Deng L, Luo X, Wang L and
Liu L: Upregulation of SPAG6 in myelodysplastic syndrome: Knockdown
inhibits cell proliferation via AKT/FOXO Signaling Pathway. DNA
Cell Biol. 38:476–484. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Di Cristofano A and Pandolfi PP: The
multiple roles of PTEN in tumor suppression. Cell. 100:387–390.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao L, Shan Y, Liu B, Li Y and Jia L:
Retraction note: Functional screen analysis reveals miR-3142 as
central regulator in chemoresistance and proliferation through
activation of the PTEN-AKT pathway in CML. Cell Death Dis.
11:1212020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yin J, Li X, Zhang Z, Luo X, Wang L and
Liu L: SPAG6 silencing induces apoptosis in the myelodysplastic
syndrome cell line SKM1 via the PTEN/PI3K/AKT signaling pathway
in vitro and in vivo. Int J Oncol. 53:297–306.
2018.PubMed/NCBI
|
|
35
|
Gehringer F, Weissinger SE, Moller P,
Wirth T and Ushmorov A: Physiological levels of the PTEN-PI3K-AKT
axis activity are required for maintenance of Burkitt lymphoma.
Leukemia. 34:857–871. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim AH, Khursigara G, Sun X, Franke TF and
Chao MV: Akt phosphorylates and negatively regulates apoptosis
signal- regulating kinase 1. Mol Cell Biol. 21:893–901. 2001.
View Article : Google Scholar : PubMed/NCBI
|
